China’s chemogenetic therapy trial cuts seizures in epilepsy patients by 92.6% - South China Morning Post
Direct Source Verification:
This story is aggregated from South China Morning Post (scmp.com). Full reporting rights and copyright belong to the primary publisher.
China’s chemogenetic therapy trial cuts seizures in epilepsy patients by 92.6% South China Morning Post
China’s chemogenetic therapy trial cuts seizures in epilepsy patients by 92.6% South China Morning Post
Original Source
https://www.scmp.com/news/china/science/article/3373500/kill-switch-epilepsy-china-cuts-seizures-926-first-human-chemogenetic-trial
